NSC |
Compound |
Enrichment |
Correlation |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0352028253287042 |
0.229182 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0352028253287042 |
0.31816107 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0352028253287042 |
0.2030839 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0352028253287042 |
-0.044364804 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.0352028253287042 |
-0.0046704981 |
NSC 758670 |
TANNIC ACID |
0.0352028253287042 |
0.11102173 |
NSC 73048 |
Null |
0.0361455178924426 |
-0.20561068 |
NSC 639734 |
Null |
0.0376362543535812 |
0.014968468 |
NSC 653153 |
Null |
0.0376362543535812 |
0.040550176 |
NSC 659948 |
7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone |
0.0376362543535812 |
-0.0010935961 |